Squarepoint’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Sell
38,700
-36,300
-48% -$11.9M 0.01% 1007
2025
Q4
$26.3M Sell
75,000
-32,100
-30% -$10.8M 0.03% 617
2025
Q3
$34.6M Buy
107,100
+81,400
+317% +$25.3M 0.03% 532
2025
Q2
$10M Sell
25,700
-6,800
-21% -$2.74M 0.01% 1067
2025
Q1
$14.1M Sell
32,500
-52,700
-62% -$21.2M 0.02% 866
2024
Q4
$31.4M Buy
85,200
+82,600
+3,177% +$34.6M 0.03% 553
2024
Q3
$1.35M Buy
2,600
+2,200
+550% +$1.18M ﹤0.01% 2369
2024
Q2
$217K Sell
400
-600
-60% -$317K ﹤0.01% 3617
2024
Q1
$519K Sell
1,000
-4,600
-82% -$2.29M ﹤0.01% 3024
2023
Q4
$2.64M Buy
5,600
+2,400
+75% +$1.11M 0.01% 1817
2023
Q3
$1.39M Sell
3,200
-2,100
-40% -$953K ﹤0.01% 2081
2023
Q2
$2.35M Buy
5,300
+4,000
+308% +$1.85M 0.01% 1553
2023
Q1
$598K Buy
+1,300
New +$619K ﹤0.01% 2202
2022
Q4
Sell
-700
Closed -$318K 3280
2022
Q3
$318K Sell
700
-10,200
-94% -$4.88M ﹤0.01% 2450
2022
Q2
$5.26M Buy
10,900
+9,500
+679% +$4.7M 0.03% 650
2022
Q1
$688K Buy
+1,400
New +$640K ﹤0.01% 1819
2021
Q4
Sell
-2,000
Closed -$746K 3249
2021
Q3
$746K Sell
2,000
-7,300
-78% -$2.77M ﹤0.01% 1740
2021
Q2
$3.55M Buy
9,300
+800
+9% +$306K 0.01% 887
2021
Q1
$3.05M Buy
+8,500
New +$2.73M 0.02% 859

Other funds holding ELV

Squarepoint's ELV Position: Q1 2026 in Review

Squarepoint reduced its Elevance Health (ELV) stake by 0.86% in Q1 2026, selling an estimated $18.4K and leaving 6,480 shares worth $1.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Squarepoint first reported a position in ELV in Q2 2015 and has held it in 40 quarters since. The position peaked at $217M in Q4 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Squarepoint held 6,480 shares of Elevance Health worth $1.9M as of Q1 2026.
  • Squarepoint sold 56 Elevance Health shares in Q1 2026, an estimated $18.4K.
  • Elevance Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2221 holding.
  • Squarepoint first reported a position in Elevance Health in Q2 2015 and has held it in 40 quarters since.
  • Squarepoint's Elevance Health position peaked at $217M in Q4 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.